Optogenetic-controlled cancer vaccines represent a cutting-edge frontier in synthetic immunology, blending optogenetics (using light to control genetically modified cells) with immunotherapy. This approach tackles a massive hurdle in oncology: how to spark a powerful, long-lasting immune response against tumors without causing severe systemic toxicity
Optogenetic-controlled cancer vaccines represent a cutting-edge frontier in synthetic immunology, blending optogenetics (using light to control genetically modified cells) with immunotherapy. This approach tackles a massive hurdle in oncology: how to spark a powerful, long-lasting immune response against tumors without causing severe systemic toxicity